IMerge Subgroup Analysis
Phase III IMerge Subgroup Analysis: Imetelstat for Achieving Transfusion Independence in ESA R/R or Ineligible Lower-Risk MDS

Released: December 11, 2023

Activity

Progress
1
Course Completed